Group | Number of patients | AI (SD) | P value | SMI/AI (SD) | P value |
---|---|---|---|---|---|
*T Stage | 0.007 | 0.06 | |||
T1 | 6 | 4.0 (5.5) | 3.4 (2.6) | ||
T2 | 45 | 10.4 (6.8) | 2.5 (1.2) | ||
T3 | 44 | 15.5 (10.7) | 2.8 (2.0) | ||
T4 | 35 | 14.1 (10.6) | 3.3 (2.6) | ||
**N Stage | 0.007 | 0.02 | |||
N0 | 27 | 8.3 (7.0) | 2.5 (1.3) | ||
N1 | 69 | 12.3 (8.2) | 3.0 (2.0) | ||
N2 | 32 | 17.0 (12.2) | 2.7 (2.2) | ||
N3 | 2 | 26.0 (4.6) | 2.4 (1.4) | ||
***M Stage | 0.02 | 0.013 | |||
M0 | 114 | 12.3 (9.3) | 2.7 (1.6) | ||
M1 | 16 | 16.4 (11.4) | 4.0 (3.4) | ||
Clinical stage | |||||
Stage 1 | 6 | 5.0 (5.1) | 3.0 (2.3) | ||
Stage 2 | 44 | 10.2 (6.7) | 0.009 | 2.4 (1.0) | 0.30 |
Stage 3 | 64 | 14.5 (10.5) | 2.9 (1.9) | ||
Stage 4 | 16 | 16.4 (11.4) | 3.4 (0.8) |